Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Who Should Take Lormalzi? Alzheimer's Expert Explains Benefits And Risks

    1 hour ago

    Neurologists say Lormalzi (donanemab), India's newly launched Alzheimer's therapy, may help slow cognitive decline in carefully selected patients with early disease. Experts explain who may benefit, who should avoid it, and the risks involved.
    Click here to Read More
    Previous Article
    Can A Simple 2-Finger Pulse Test Reveal Heart Problems? Doctor Explains
    Next Article
    Children In Bihar Seen Playing With Endangered Gangetic Dolphin, Video Sparks Outrage

    Related Breaking News Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment